| - GRCh37:
- Chr19:8941823-13442041
- GRCh38:
- Chr19:8831147-13331227
| ACP5, ANGPTL6, ANGPTL8, AP1M2, ATG4D, BEST2, C19orf38, CACNA1A, CALR, CARM1, CCDC159, CDC37, CDKN2D, CNN1, COL5A3, DAND5, DHPS, DNASE2, DNM2, DNMT1, DOCK6, ECSIT, EIF3G, ELAVL3, ELOF1, EPOR, FARSA, FARSA-AS1, FBXL12, FBXW9, FDX2, FDX2-ZGLP1, GADD45GIP1, GCDH, GET3, GNG14, HOOK2, ICAM1, ICAM3, ICAM4, ICAM5, IER2, ILF3, ILF3-DT, JUNB, KANK2, KEAP1, KLF1, KRI1, LDLR, LDLR-AS1, LIMASI, LINC02926, LOC100505555, LOC105372273, LOC107080555, LOC108663985, LOC110121441, LOC110121458, LOC112543445, LOC112543446, LOC112543448, LOC112543452, LOC112543454, LOC112543455, LOC112543458, LOC113939967, LOC116276501, LOC116276502, LOC116276503, LOC117038783, LOC117038784, LOC117038785, LOC117038786, LOC117038787, LOC117038788, LOC117038789, LOC117038790, LOC117038791, LOC117038792, LOC117038793, LOC117038794, LOC117038795, LOC117125585, LOC117125586, LOC117125587, LOC117125588, LOC117125589, LOC117125590, LOC117125591, LOC117125592, LOC117125593, LOC117125594, LOC117125595, LOC117125596, LOC117125597, LOC117125598, LOC121852977, LOC121852978, LOC121852979, LOC121852980, LOC125371473, LOC125371474, LOC125371475, LOC125371476, LOC125371477, LOC125371478, LOC125371479, LOC125371480, LOC125371481, LOC126862848, LOC126862849, LOC126862850, LOC126862851, LOC126862852, LOC126862853, LOC126862854, LOC126862855, LOC126862856, LOC126862857, LOC126862858, LOC126862859, LOC126862860, LOC126862861, LOC126862862, LOC126862863, LOC126862864, LOC126862865, LOC648044, LYL1, MAN2B1, MAST1, MBD3L1, MIR1181, MIR1238, MIR199A1, MIR4322, MIR4748, MIR5589, MIR5684, MIR5695, MIR638, MIR6515, MIR6793, MIR6794, MIR6886, MIR7974, MRPL4, MUC16, NACC1, NFIX, ODAD3, OLFM2, OR1M1, OR7D2, OR7D4, OR7E24, OR7G1, OR7G2, OR7G3, P2RY11, PDE4A, PIN1, PIN1-DT, PLPPR2, PPAN, PPAN-P2RY11, PRDX2, PRKCSH, QTRT1, RAB3D, RAD23A, RAVER1, RDH8, RGL3, RNASEH2A, RTBDN, S1PR2, S1PR5, SHFL, SLC44A2, SMARCA4, SNORD105, SNORD105B, SNORD135, SNORD41, SPC24, STX10, SWSAP1, SYCE2, THSD8, TIMM29, TMED1, TMEM205, TNPO2, TRIR, TRMT1, TSPAN16, TYK2, UBL5, WDR83, WDR83OS, YIPF2, ZGLP1, ZNF121, ZNF136, ZNF177, ZNF20, ZNF266, ZNF317, ZNF426, ZNF426-DT, ZNF433, ZNF433-AS1, ZNF439, ZNF44, ZNF440, ZNF441, ZNF442, ZNF443, ZNF490, ZNF491, ZNF558, ZNF559, ZNF559-ZNF177, ZNF560, ZNF561, ZNF561-AS1, ZNF562, ZNF563, ZNF564, ZNF625, ZNF625-ZNF20, ZNF627, ZNF653, ZNF69, ZNF699, ZNF700, ZNF709, ZNF763, ZNF791, ZNF799, ZNF823, ZNF844, ZNF846, ZNF878 | | See cases | Likely pathogenic (May 6, 2011) | no assertion criteria provided |
| - GRCh37:
- Chr19:9846119-11338677
- GRCh38:
- Chr19:9735443-11228001
| ANGPTL6, AP1M2, ATG4D, C19orf38, CARM1, CDC37, CDKN2D, COL5A3, DNM2, DNMT1, DOCK6, EIF3G, FBXL12, FDX2, FDX2-ZGLP1, ICAM1, ICAM3, ICAM4, ICAM5, ILF3, ILF3-DT, KANK2, KEAP1, KRI1, LDLR, LDLR-AS1, LIMASI, LOC100505555, LOC105372273, LOC107080555, LOC110121441, LOC113939967, LOC116276501, LOC116276502, LOC125371474, LOC125371475, LOC125371476, LOC125371477, LOC126862852, LOC126862853, LOC126862854, LOC126862855, LOC126862856, MIR1181, MIR1238, MIR199A1, MIR4322, MIR4748, MIR5589, MIR638, MIR6793, MIR6886, MRPL4, OLFM2, P2RY11, PDE4A, PIN1, PIN1-DT, PPAN, PPAN-P2RY11, QTRT1, RAVER1, RDH8, S1PR2, S1PR5, SHFL, SLC44A2, SMARCA4, SNORD105, SNORD105B, SPC24, TIMM29, TMED1, TYK2, UBL5, YIPF2, ZGLP1, ZNF846 | | See cases | Pathogenic (Jul 30, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr19:10425934-14159806
- GRCh38:
- Chr19:10315258-14048994
| ACP5, ANGPTL8, AP1M2, ATG4D, BEST2, BRME1, C19orf38, C19orf53, CACNA1A, CALR, CARM1, CC2D1A, CCDC159, CDC37, CDKN2D, CNN1, DAND5, DCAF15, DHPS, DNASE2, DNM2, DOCK6, ECSIT, ELAVL3, ELOF1, EPOR, FARSA, FARSA-AS1, FBXW9, FDX2, FDX2-ZGLP1, GADD45GIP1, GCDH, GET3, GNG14, HOOK2, ICAM3, IER2, IL27RA, ILF3, ILF3-DT, JUNB, KANK2, KEAP1, KLF1, KRI1, LDLR, LDLR-AS1, LINC02926, LOC105372273, LOC108663985, LOC110121441, LOC110121458, LOC111365163, LOC112543445, LOC112543446, LOC112543448, LOC112543452, LOC112543454, LOC112543455, LOC112543458, LOC112543459, LOC116276503, LOC116276504, LOC116276505, LOC117038783, LOC117038784, LOC117038785, LOC117038786, LOC117038787, LOC117038788, LOC117038789, LOC117038790, LOC117038791, LOC117038792, LOC117038793, LOC117038794, LOC117038795, LOC117125585, LOC117125586, LOC117125587, LOC117125588, LOC117125589, LOC117125590, LOC117125591, LOC117125592, LOC117125593, LOC117125594, LOC117125595, LOC117125596, LOC117125597, LOC117125598, LOC121852977, LOC121852978, LOC121852979, LOC121852980, LOC121852981, LOC125371477, LOC125371478, LOC125371479, LOC125371480, LOC125371481, LOC126862855, LOC126862856, LOC126862857, LOC126862858, LOC126862859, LOC126862860, LOC126862861, LOC126862862, LOC126862863, LOC126862864, LOC126862865, LOC126862866, LOC648044, LYL1, MAN2B1, MAST1, MIR1181, MIR1238, MIR181C, MIR181D, MIR199A1, MIR23A, MIR23AHG, MIR24-2, MIR27A, MIR4748, MIR5684, MIR5695, MIR638, MIR6515, MIR6793, MIR6794, MIR6886, MIR7974, MRI1, NACC1, NANOS3, NFIX, ODAD3, PDE4A, PLPPR2, PODNL1, PRDX2, PRKCSH, QTRT1, RAB3D, RAD23A, RAVER1, RFX1, RGL3, RLN3, RNASEH2A, RTBDN, S1PR5, SLC44A2, SMARCA4, SNORD135, SNORD41, SPC24, STX10, SWSAP1, SYCE2, THSD8, TIMM29, TMED1, TMEM205, TNPO2, TRIR, TRMT1, TSPAN16, TYK2, WDR83, WDR83OS, YIPF2, YJU2B, ZNF136, ZNF20, ZNF433, ZNF433-AS1, ZNF439, ZNF44, ZNF440, ZNF441, ZNF442, ZNF443, ZNF490, ZNF491, ZNF563, ZNF564, ZNF625, ZNF625-ZNF20, ZNF627, ZNF653, ZNF69, ZNF700, ZNF709, ZNF763, ZNF791, ZNF799, ZNF823, ZNF844, ZNF878, ZSWIM4 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr19:10430150-13888674
- GRCh38:
- Chr19:10319474-13777860
| ACP5, ANGPTL8, AP1M2, ATG4D, BEST2, C19orf38, C19orf53, CACNA1A, CALR, CARM1, CCDC159, CDC37, CDKN2D, CNN1, DAND5, DHPS, DNASE2, DNM2, DOCK6, ECSIT, ELAVL3, ELOF1, EPOR, FARSA, FARSA-AS1, FBXW9, GADD45GIP1, GCDH, GET3, GNG14, HOOK2, ICAM3, IER2, ILF3, ILF3-DT, JUNB, KANK2, KEAP1, KLF1, KRI1, LDLR, LDLR-AS1, LINC02926, LOC105372273, LOC108663985, LOC110121441, LOC110121458, LOC111365163, LOC112543445, LOC112543446, LOC112543448, LOC112543452, LOC112543454, LOC112543455, LOC112543458, LOC112543459, LOC116276503, LOC117038783, LOC117038784, LOC117038785, LOC117038786, LOC117038787, LOC117038788, LOC117038789, LOC117038790, LOC117038791, LOC117038792, LOC117038793, LOC117038794, LOC117038795, LOC117125585, LOC117125586, LOC117125587, LOC117125588, LOC117125589, LOC117125590, LOC117125591, LOC117125592, LOC117125593, LOC117125594, LOC117125595, LOC117125596, LOC117125597, LOC117125598, LOC121852977, LOC121852978, LOC121852979, LOC121852980, LOC121852981, LOC125371477, LOC125371478, LOC125371479, LOC125371480, LOC125371481, LOC126862855, LOC126862856, LOC126862857, LOC126862858, LOC126862859, LOC126862860, LOC126862861, LOC126862862, LOC126862863, LOC126862864, LOC126862865, LOC126862866, LOC648044, LYL1, MAN2B1, MAST1, MIR1181, MIR1238, MIR199A1, MIR4748, MIR5684, MIR5695, MIR638, MIR6515, MIR6793, MIR6794, MIR6886, MIR7974, MRI1, NACC1, NFIX, ODAD3, PDE4A, PLPPR2, PRDX2, PRKCSH, QTRT1, RAB3D, RAD23A, RAVER1, RGL3, RNASEH2A, RTBDN, S1PR5, SLC44A2, SMARCA4, SNORD135, SNORD41, SPC24, STX10, SWSAP1, SYCE2, THSD8, TIMM29, TMED1, TMEM205, TNPO2, TRIR, TRMT1, TSPAN16, TYK2, WDR83, WDR83OS, YIPF2, YJU2B, ZNF136, ZNF20, ZNF433, ZNF433-AS1, ZNF439, ZNF44, ZNF440, ZNF441, ZNF442, ZNF443, ZNF490, ZNF491, ZNF563, ZNF564, ZNF625, ZNF625-ZNF20, ZNF627, ZNF653, ZNF69, ZNF700, ZNF709, ZNF763, ZNF791, ZNF799, ZNF823, ZNF844, ZNF878 | | See cases | Pathogenic (Oct 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr19:11071560
- GRCh38:
- Chr19:10960884
| SMARCA4 | | not provided | Benign (Jun 18, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11071810
- GRCh38:
- Chr19:10961134
| SMARCA4 | | Coffin-Siris syndrome | Likely benign (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11071839
- GRCh38:
- Chr19:10961163
| SMARCA4 | | Coffin-Siris syndrome, not provided | Likely benign (Mar 28, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11071861
- GRCh38:
- Chr19:10961185
| SMARCA4 | | Coffin-Siris syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11071879
- GRCh38:
- Chr19:10961203
| SMARCA4 | | not provided | Benign (Jun 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11071884
- GRCh38:
- Chr19:10961208
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11071918
- GRCh38:
- Chr19:10961242
| SMARCA4 | | not provided | Likely benign (Jul 8, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094591
- GRCh38:
- Chr19:10983915
| SMARCA4 | | not provided | Likely benign (Jun 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094789
- GRCh38:
- Chr19:10984113
| SMARCA4 | | not provided | Uncertain significance (Feb 12, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094791
- GRCh38:
- Chr19:10984115
| SMARCA4 | | Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094797-11172958
- GRCh38:
- Chr19:10984121-11062282
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Pathogenic (Oct 24, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094818-11107066
- GRCh38:
- Chr19:10984142-10996390
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (May 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094823
- GRCh38:
- Chr19:10984147
| SMARCA4 | | Hereditary cancer-predisposing syndrome | Uncertain significance (Oct 29, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094830
- GRCh38:
- Chr19:10984154
| SMARCA4 | M1I | Neurodevelopmental disorder, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094833
- GRCh38:
- Chr19:10984157
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome, not specified
| Likely benign (Apr 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094834
- GRCh38:
- Chr19:10984158
| SMARCA4 | T3A | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094834
- GRCh38:
- Chr19:10984158
| SMARCA4 | T3P | Intellectual disability, autosomal dominant 16, Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome
| Uncertain significance (Jun 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094835
- GRCh38:
- Chr19:10984159
| SMARCA4 | T3N | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094835
- GRCh38:
- Chr19:10984159
| SMARCA4 | T3I | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (May 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094836
- GRCh38:
- Chr19:10984160
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome | Likely benign (May 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094837
- GRCh38:
- Chr19:10984161
| SMARCA4 | P4A | Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome | Uncertain significance (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094837
- GRCh38:
- Chr19:10984161
| SMARCA4 | P4S | Rhabdoid tumor predisposition syndrome 2, not provided | Uncertain significance (Aug 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094838
- GRCh38:
- Chr19:10984162
| SMARCA4 | P4Q | Hereditary cancer-predisposing syndrome | Uncertain significance (Mar 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094840
- GRCh38:
- Chr19:10984164
| SMARCA4 | D5H | Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094842
- GRCh38:
- Chr19:10984166
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094844
- GRCh38:
- Chr19:10984168
| SMARCA4 | P6Q | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094846
- GRCh38:
- Chr19:10984170
| SMARCA4 | P7T | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094847
- GRCh38:
- Chr19:10984171
| SMARCA4 | P7R | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094847
- GRCh38:
- Chr19:10984171
| SMARCA4 | P7H | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2, Intellectual disability, autosomal dominant 16
| Uncertain significance (Sep 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094848
- GRCh38:
- Chr19:10984172
| SMARCA4 | | Hereditary cancer-predisposing syndrome | Likely benign (Nov 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094848
- GRCh38:
- Chr19:10984172
| SMARCA4 | | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Likely benign (Apr 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094849
- GRCh38:
- Chr19:10984173
| SMARCA4 | L8M | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Jun 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094849
- GRCh38:
- Chr19:10984173
| SMARCA4 | | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Likely benign (Aug 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094851
- GRCh38:
- Chr19:10984175
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (Jan 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094851
- GRCh38:
- Chr19:10984175
| SMARCA4 | | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Likely benign (Jul 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094852
- GRCh38:
- Chr19:10984176
| SMARCA4 | G9S | Hereditary cancer-predisposing syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094853
- GRCh38:
- Chr19:10984177
| SMARCA4 | G9D | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094854
- GRCh38:
- Chr19:10984178
| SMARCA4 | | Hereditary cancer-predisposing syndrome | Likely benign (Mar 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094854
- GRCh38:
- Chr19:10984178
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome | Likely benign (Jul 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094854
- GRCh38:
- Chr19:10984178
| SMARCA4 | | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Likely benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094855
- GRCh38:
- Chr19:10984179
| SMARCA4 | G10R | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094858
- GRCh38:
- Chr19:10984182
| SMARCA4 | T11A | Rhabdoid tumor predisposition syndrome 2, Intellectual disability, autosomal dominant 16, Hereditary cancer-predisposing syndrome
| Uncertain significance (Feb 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094859
- GRCh38:
- Chr19:10984183
| SMARCA4 | T11S | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Dec 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094859
- GRCh38:
- Chr19:10984183
| SMARCA4 | T11I | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Jun 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094860
- GRCh38:
- Chr19:10984184
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (May 16, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094861
- GRCh38:
- Chr19:10984185
| SMARCA4 | P12S | Hereditary cancer-predisposing syndrome | Uncertain significance (Oct 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094862
- GRCh38:
- Chr19:10984186
| SMARCA4 | P12L | Intellectual disability, autosomal dominant 16, Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2
| Uncertain significance (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094863
- GRCh38:
- Chr19:10984187
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (May 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094864
- GRCh38:
- Chr19:10984188
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094864
- GRCh38:
- Chr19:10984188
| SMARCA4 | R13W | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Jul 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094865
- GRCh38:
- Chr19:10984189
| SMARCA4 | R13L | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094865
- GRCh38:
- Chr19:10984189
| SMARCA4 | R13P | Hereditary cancer-predisposing syndrome | Uncertain significance (Aug 27, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094865
- GRCh38:
- Chr19:10984189
| SMARCA4 | R13Q | Intellectual disability, autosomal dominant 16, Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2
| Uncertain significance (Apr 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094866
- GRCh38:
- Chr19:10984190
| SMARCA4 | | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Likely benign (Jul 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094866
- GRCh38:
- Chr19:10984190
| SMARCA4 | | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Likely benign (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094867-11094868
- GRCh38:
- Chr19:10984191-10984192
| SMARCA4 | P14E | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094867
- GRCh38:
- Chr19:10984191
| SMARCA4 | P14T | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Mar 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094869
- GRCh38:
- Chr19:10984193
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (Apr 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094869
- GRCh38:
- Chr19:10984193
| SMARCA4 | | Hereditary cancer-predisposing syndrome | Likely benign (Jan 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094871
- GRCh38:
- Chr19:10984195
| SMARCA4 | G15D | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Apr 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094871
- GRCh38:
- Chr19:10984195
| SMARCA4 | G15A | Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 7, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094871
- GRCh38:
- Chr19:10984195
| SMARCA4 | G15V | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094874
- GRCh38:
- Chr19:10984198
| SMARCA4 | P16R | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Jun 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094877
- GRCh38:
- Chr19:10984201
| SMARCA4 | S17F | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094878
- GRCh38:
- Chr19:10984202
| SMARCA4 | | Hereditary cancer-predisposing syndrome | Likely benign (Oct 6, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094878
- GRCh38:
- Chr19:10984202
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (Nov 21, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094878
- GRCh38:
- Chr19:10984202
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome | Likely benign (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094880
- GRCh38:
- Chr19:10984204
| SMARCA4 | P18L | Hereditary cancer-predisposing syndrome, Intellectual disability, autosomal dominant 16, not provided, Rhabdoid tumor predisposition syndrome 2 | Conflicting interpretations of pathogenicity (Aug 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr19:11094881
- GRCh38:
- Chr19:10984205
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (Nov 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094881
- GRCh38:
- Chr19:10984205
| SMARCA4 | | Intellectual disability, autosomal dominant 16, Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome
| Benign/Likely benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094883
- GRCh38:
- Chr19:10984207
| SMARCA4 | G19A | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Nov 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094884
- GRCh38:
- Chr19:10984208
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094884
- GRCh38:
- Chr19:10984208
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome | Likely benign (Jan 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094890
- GRCh38:
- Chr19:10984214
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (Aug 22, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094891
- GRCh38:
- Chr19:10984215
| SMARCA4 | P22A | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094891
- GRCh38:
- Chr19:10984215
| SMARCA4 | P22S | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094892
- GRCh38:
- Chr19:10984216
| SMARCA4 | P22H | Intellectual disability, autosomal dominant 16, Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2
| Uncertain significance (Feb 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094892
- GRCh38:
- Chr19:10984216
| SMARCA4 | P22L | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2, Intellectual disability, autosomal dominant 16
| Uncertain significance (May 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094892
- GRCh38:
- Chr19:10984216
| SMARCA4 | P22R | Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome | Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094893
- GRCh38:
- Chr19:10984217
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome | Likely benign (May 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094895
- GRCh38:
- Chr19:10984219
| SMARCA4 | S23F | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Nov 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094895
- GRCh38:
- Chr19:10984219
| SMARCA4 | S23C | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094895
- GRCh38:
- Chr19:10984219
| SMARCA4 | S23Y | Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 16, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094896
- GRCh38:
- Chr19:10984220
| SMARCA4 | | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Likely benign (Mar 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094896
- GRCh38:
- Chr19:10984220
| SMARCA4 | | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Likely benign (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094897-11094926
- GRCh38:
- Chr19:10984221-10984250
| SMARCA4 | | Hereditary cancer-predisposing syndrome | Uncertain significance (Nov 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094897
- GRCh38:
- Chr19:10984221
| SMARCA4 | P24S | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094897
- GRCh38:
- Chr19:10984221
| SMARCA4 | P24A | not provided, Hereditary cancer-predisposing syndrome, Intellectual disability, autosomal dominant 16, Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094898
- GRCh38:
- Chr19:10984222
| SMARCA4 | P24R | Rhabdoid tumor predisposition syndrome 2, Intellectual disability, autosomal dominant 16, Hereditary cancer-predisposing syndrome
| Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094899
- GRCh38:
- Chr19:10984223
| SMARCA4 | | Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 | Likely benign (Jun 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094900
- GRCh38:
- Chr19:10984224
| SMARCA4 | G25R | Rhabdoid tumor predisposition syndrome 2 | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094900-11094902
- GRCh38:
- Chr19:10984224-10984226
| SMARCA4 | G25del | Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome, Intellectual disability, autosomal dominant 16
| Uncertain significance (Jul 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11094902
- GRCh38:
- Chr19:10984226
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094902
- GRCh38:
- Chr19:10984226
| SMARCA4 | | Rhabdoid tumor predisposition syndrome 2 | Likely benign (Nov 21, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094903
- GRCh38:
- Chr19:10984227
| SMARCA4 | A26P | Hereditary cancer-predisposing syndrome | Uncertain significance (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11094903
- GRCh38:
- Chr19:10984227
| SMARCA4 | A26T | not provided, Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2, Intellectual disability, autosomal dominant 16 | Conflicting interpretations of pathogenicity (Oct 31, 2022) | criteria provided, conflicting interpretations |